Titlebook: Benign Prostatic Hyperplasia; Innovations in Manag Zbigniew Petrovich (Professor and Chairman),Luc Ba Book 1994 Springer-Verlag Berlin Heid

芭蕾舞女演員

要控制

異常

,Pathogenesis of Benign Prostatic Hyperplasia: Potential Role of Mesenchymal — Epithelial Interactiog luteinizing hormone-releasing hormone agonists (O. 1991b) or interference with androgen action by administration of androgen antagonists (S. and C. 1991) or 5α-reductase inhibitors (G. al. 1991) reduces the volume of the prostate in patients with BPH.

朋黨派系

The Use of Pharmacologic Agents for Benign Prostatic Hyperplasia,icing urologists in the United States with regard to morbidity and mortality. These results are summarized in Table 12.1. although relatively uncommon, the complications from TURP are significant (see Chap. 8).

罐里有戒指

BARB

Etiology of Benign Prostatic Hyperplasia: Can this Disease Be Prevented?,gic entity (which we will denote as pBPH) and of the clinical diagnosis of BPH (cBPH). Discussion of the issues involved in the decision as to whether and how to treat cBPH can be found in other chapters of this book.

主講人

Chromosome Abnormalities in Benign Prostatic Hyperplasia,malities have been reported in about 1000 epithelial tumors and a small number of characteristic changes have been identified in these tumors, particularly in those of common occurrence such as tumors of the breast, lung, large bowel, ovary, and prostate (M. 1991).

BABY

Evaluation of End Points in the Treatment of Benign Prostatic Hyperplasia,d a concomitant increase in detrusor pressure which may eventually progress to decompensation of the lower urinary tract. This may be associated with bladder changes such as trabeculation and with upper urinary tract deterioration including hydronephrosis and renal compromise.

Affirm

Progress in Surgery for Benign Prostatic Hyperplasia,tion of the surgeon (Fig. 8.1). In the United States, 90% of prostatectomies for BPH are performed transurethraly and approximately 400 000 TURPs are performed annually. The procedure is considered relatively free of life-threatening complications, and in most patients a satisfactory outcome is achieved, though significant problems can occur.

INCH

Prostatic Balloon Dilation,at least seems to be so in the English-written literature. Attempts to distinguish between these two words based on different meanings, i.e. a performance versus a condition, cannot be supported historically either (B. et al. 1992).